Patients with multiple myeloma exhibiting poor prognostic features, such as high-risk cytogenetics, soft-tissue plasmacytoma, ISS stage III disease, and triple-class exposure, experienced significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results